I-MAB (IMAB)
1.80
-0.01
(-0.55%)
USD |
NASDAQ |
Apr 26, 16:00
1.805
0.00 (0.00%)
After-Hours: 20:00
I-MAB Cash and Short Term Investments (Quarterly): 406.06M for June 30, 2023
Cash and Short Term Investments (Quarterly) Chart
Historical Cash and Short Term Investments (Quarterly) Data
Date | Value |
---|---|
December 31, 2023 | 322.30M |
June 30, 2023 | 406.06M |
June 30, 2023 | 406.06M |
December 31, 2022 | 499.97M |
June 30, 2022 | 585.23M |
June 30, 2022 | 585.23M |
December 31, 2021 | 670.97M |
June 30, 2021 | 736.93M |
June 30, 2021 | 736.93M |
Date | Value |
---|---|
December 31, 2020 | 733.21M |
September 30, 2020 | 437.79M |
June 30, 2020 | 220.27M |
June 30, 2020 | 220.27M |
December 31, 2019 | 167.14M |
September 30, 2019 | 188.22M |
June 30, 2019 | 195.94M |
June 30, 2019 | 195.94M |
December 31, 2018 | 268.10M |
Cash and Short Term Investments Definition
Cash and Short Term investments is the sum of two balance sheet line items: cash and equivalents and short term investments in marketable securities.
Cash and Short Term Investments (Quarterly) Range, Past 5 Years
167.14M
Minimum
Dec 2019
736.93M
Maximum
Jun 2021
429.91M
Average
406.06M
Median
Jun 2023
Cash and Short Term Investments (Quarterly) Benchmarks
Zai Lab Ltd | 806.45M |
WuXi Biologics (Cayman) Inc | 1.586B |
Wuxi AppTec Co Ltd | 1.943B |
Gracell Biotechnologies Inc (DELISTED) | 234.08M |
Sinovac Biotech Ltd | 11.07B |